Curtis Lockshin
CIK: 0001383556
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PHIO
Phio Pharmaceuticals Corp.
Director
Discretionary Trading P&L
Holdings
About Lockshin Curtis
Lockshin Curtis (SEC CIK 0001383556) files insider reports with the SEC as Director of Phio Pharmaceuticals Corp. (PHIO).
Signal8 holds 3 ownership filings by Lockshin Curtis, all Form 4s, filed between Sep 12, 2024 and Feb 6, 2026. Those filings report 3 transactions, from Sep 11, 2024 to Feb 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lockshin Curtis's filings is in KING OF PRUSSIA, PA.
Recent filings by Lockshin Curtis
Other insiders filing for Phio Pharmaceuticals Corp. (PHIO)
- Carson Lisa Cabott, Chief Financial Officer
- Bitterman Robert J, Chairman, Pres. & CEO
- Plott Ronald Todd, Director
- BRADFORD PATRICIA A, Director
- Freeman Jonathan E, Director
- Deming David H, Director